Gilead Inc said on Friday that the US Food and Drug Administration has authorised expanded emergency use for its experimental antiviral Covid 19 treatment , remdesivir . 
The drug can now be used to treat all hospitalised patients with coronavirus in addition to patients with a severe form of the illness . 
